Michael J Donovan

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. doi request reprint Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes
    Michael J Donovan
    Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA
    Mol Diagn Ther . 2016
  2. doi request reprint Predicting high-risk disease using tissue biomarkers
    Michael J Donovan
    Department of Pathology, Mt Sinai School of Medicine, New York City, NY 10029 6574, USA
    Curr Opin Urol 23:245-51. 2013
  3. doi request reprint Personalized prediction of tumor response and cancer progression on prostate needle biopsy
    Michael J Donovan
    Aureon Laboratories, Inc, New York, New York 10701, USA
    J Urol 182:125-32. 2009
  4. doi request reprint Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease
    Michael J Donovan
    Aureon Laboratories, Yonkers, New York, NY, USA
    BJU Int 105:462-7. 2010
  5. doi request reprint Systems pathology: a paradigm shift in the practice of diagnostic and predictive pathology
    Michael J Donovan
    Aureon Laboratories, Yonkers, New York, USA
    Cancer 115:3078-84. 2009
  6. pmc Improved prediction of prostate cancer recurrence through systems pathology
    Carlos Cordon-Cardo
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Invest 117:1876-83. 2007
  7. pmc Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains
    Jimmy L Huynh
    1 Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York, USA 2 Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA
    Nat Neurosci 17:121-30. 2014
  8. doi request reprint Genomic analysis in active surveillance: predicting high-risk disease using tissue biomarkers
    Michael J Donovan
    Icahn School of Medicine at Mt Sinai, Department of Pathology, New York, New York, USA
    Curr Opin Urol 24:303-10. 2014
  9. doi request reprint Overcoming tumor heterogeneity in the molecular diagnosis of urological cancers
    Michael J Donovan
    Department of Pathology, Icahn School of Medicine, 1468 Madison Avenue, New York City, NY 10029, USA
    Expert Rev Mol Diagn 14:1023-31. 2014

Collaborators

Detail Information

Publications9

  1. doi request reprint Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes
    Michael J Donovan
    Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA
    Mol Diagn Ther . 2016
    ..e. blood, urine) analytics as drivers of next generation precise patient phenotyping...
  2. doi request reprint Predicting high-risk disease using tissue biomarkers
    Michael J Donovan
    Department of Pathology, Mt Sinai School of Medicine, New York City, NY 10029 6574, USA
    Curr Opin Urol 23:245-51. 2013
    ..We will provide an overview of current prostate cancer biomarker discovery and validation strategies that are geared toward identifying aggressive, clinically significant disease at the time of diagnosis...
  3. doi request reprint Personalized prediction of tumor response and cancer progression on prostate needle biopsy
    Michael J Donovan
    Aureon Laboratories, Inc, New York, New York 10701, USA
    J Urol 182:125-32. 2009
    ..We developed a patient specific, biology driven tool to predict outcome at diagnosis. We also investigated whether biopsy androgen receptor levels predict a durable response to therapy after secondary treatment...
  4. doi request reprint Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease
    Michael J Donovan
    Aureon Laboratories, Yonkers, New York, NY, USA
    BJU Int 105:462-7. 2010
    ....
  5. doi request reprint Systems pathology: a paradigm shift in the practice of diagnostic and predictive pathology
    Michael J Donovan
    Aureon Laboratories, Yonkers, New York, USA
    Cancer 115:3078-84. 2009
    ..Cancer 2009;115(13 suppl):3078-84. (c) 2009 American Cancer Society...
  6. pmc Improved prediction of prostate cancer recurrence through systems pathology
    Carlos Cordon-Cardo
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Invest 117:1876-83. 2007
    ..This robust platform has broad applications in patient diagnosis, treatment management, and prognostication...
  7. pmc Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains
    Jimmy L Huynh
    1 Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York, USA 2 Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA
    Nat Neurosci 17:121-30. 2014
    ..Thus, epigenomic changes in genes affecting oligodendrocyte susceptibility to damage are detected in pathology-free areas of multiple sclerosis-affected brains. ..
  8. doi request reprint Genomic analysis in active surveillance: predicting high-risk disease using tissue biomarkers
    Michael J Donovan
    Icahn School of Medicine at Mt Sinai, Department of Pathology, New York, New York, USA
    Curr Opin Urol 24:303-10. 2014
    ..This review will provide an overview of current prostate cancer genomic and biomarker discovery - validation strategies geared towards identifying aggressive, clinically significant disease at the time of diagnosis...
  9. doi request reprint Overcoming tumor heterogeneity in the molecular diagnosis of urological cancers
    Michael J Donovan
    Department of Pathology, Icahn School of Medicine, 1468 Madison Avenue, New York City, NY 10029, USA
    Expert Rev Mol Diagn 14:1023-31. 2014
    ..Generating a comprehensive patient-centric phenotypic disease profile should generate a 'codex' which can be employed to change the current treatment decision process. ..